University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.
Researchers have developed light-sensitive chemicals that can eliminate tumors in vivo in mouse models of breast cancer with minimal side effects. | Drug Discovery And Development ...